NEOK Bio

NEOK Bio is a biotechnology company that develops novel bispecific antibody-drug conjugates (ADCs) designed to treat solid tumors with significant unmet medical needs. The company generates revenue through strategic partnerships, collaborations, and licensing agreements with healthcare providers and biopharma partners. Its key differentiator is a dual-targeting approach that aims to improve the safety and efficacy of cancer therapies compared to conventional monovalent ADCs.